NeurologyLive® Friday 5 — June 7, 2024

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Where Are We: Development of Gene and Cell Approaches for Parkinson Disease

According to recent studies and the latest insights provided by experts, early developments in gene and cell therapies show promise for patients living with Parkinson disease, but challenges remain.

2: Emerging Treatment Approaches and Medical Devices for Obstructive Sleep Apnea: Kin Yuen, MD, MS

The sleep medicine specialist at the University of California, San Francisco provided perspective on some of the innovative therapeutic strategies in development for patients with obstructive sleep apnea. [WATCH TIME: 5 minutes]

3: Recognizing the Clinical Features of MOGAD for Diagnosis: Eoin P. Flanagan, MB, BCh

The professor of neurology at Mayo Clinic talked about how MOG antibody-associated disease can be diagnosed through specific antibody tests, highlighting its distinct clinical and MRI features. [WATCH TIME: 4 minutes]

4: NeuroVoices: James Rowley, MD, on SLEEP 2024 and the Direction of the AASM

In this week's NeuroVocies Q&A, the pulmonologist at Rush Health and immediate past president of the American Academy of Sleep Medicine provided perspective on some of the intriguing changes to sleep medicine and where the field is headed in the coming years.

5: The Future Outlook for Alzheimer Disease

In episode 10 of a Peer Exchange video series, Sharon Cohen, MD, and Marwan Sabbagh, MD, share their final thoughts on Alzheimer disease and offer advice on strategies to reduce the risk of developing AD and slow the progression of the disease for those already affected.